Otolaryngology
Clemmons
ENT / Head and Neck Surgery
Medical Plaza – Clemmons
2341 Lewisville-Clemmons Road
Clemmons, NC 27012
Phone: 336-713-7827
Winston-Salem
131 Miller Street
Comp Rehab
2nd Floor
Winston Salem, NC 27157
Phone: 336-713-7827
Progressive Approaches to Otolaryngology Care
Wake Forest Baptist Medical Center's Department of Otolaryngology is a national leader in treating diseases of the ear, nose and throat. Comprehensive clinical activities focus on:
- Head and neck cancer
- Voice and swallowing disorders
- Otology, neurotology and skull base surgery
- Rhinology and allergy
- Facial plastic and reconstructive surgery
- Audiology and speech pathology
Novel Treatments for Head and Neck Disorders
Wake Forest Baptist otolaryngologists specialize in using transoral robotic surgery (TORS) to treat tumors of the tongue base, larynx and skull base. They have also developed a minimally-invasive procedure, transgastric retrograde esophagoscopy with anterograde dilatation (TREAD), to restore swallowing function in patients with hypopharyngeal and esophageal luminal stricture.
Translational Research Advances
The Department of Otolaryngology uses a bedside-to-bench-to-bedside approach to identify clinical problems and develop translational research platforms. Preclinical models focus on:
- Loss of salivary gland dysfunction: Researchers are using stem cell regenerative therapy to restore salivary function in preclinical models of head and neck cancer treatments.
- Esophageal stricture: Wake Forest Baptist researchers have developed a drug-polymer stent technology that is designed to inhibit scar tissue formation in esophageal stricture.
Current Research
Transoral Robotic Surgery (TORS) for Oral and Laryngopharyngeal Lesions Using Da Vinci Robotic Surgical System
U.S. Patents
Engineered Oral Tissue Structural Constructs
United States Patent Application 11/048,097, filed February 1, 2005.
The invention is directed to compositions and methods for preparing an artificial oral tissue.
Medical Devices Incorporating Collagen Gene Inhibitors
United States Provisional Patent Application Serial No. 60/868,217, filed December 1, 2006.
The invention comprises a novel collagen gene inhibitor applied to implantable medical devices to prevent the amelioration of scar tissue at the site of surgical wounds.
Medical Devices Incorporating Collagen Gene Inhibitors
United States Patent Application 11/948,294, filed November 30, 2007: Medical Devices Incorporating Collagen Gene Inhibitors.
The invention comprises a novel collagen gene inhibitor applied to implantable medical devices to prevent the amelioration of scar tissue at the site of surgical wounds.